Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-03

Clinical Trial Update: Trial of Naltrexone and Dextromethorphan for Gulf War Illness [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating naltrexone and dextromethorphan for Gulf War Illness has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextromethorphan (dextromethorphan)
  • Naltrexone (Naltrexone)

Snippet

Sponsor: East Carolina University | Conditions: Gulf War Illness | Phase 2 | Status: COMPLETED